The modest response of the ERα+ breast and ovarian cancer cell lines to estrogen supplementation in vitro (especially under 3D conditions) prompted us to test whether estrogen can help establish HGSC xenografts in the highly immunocompromised NSG mice. This evidence concerns the gene ESR1 and ovarian cancer.